NASDAQ: LKFT
Lakefront Biotherapeutics Nv Stock Ownership - Who owns Lakefront Biotherapeutics Nv?

Insider buying vs selling

Have Lakefront Biotherapeutics Nv insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LKFT insiders and whales buy or sell their stock.

LKFT Shareholders

What type of owners hold Lakefront Biotherapeutics Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc25.35%16,707,477$449.60MInstitution
Tang Capital Management LLC5.75%3,785,991$101.88MInstitution
Madison Avenue Partners LP3.74%2,465,179$66.34MInstitution
Ecor1 Capital LLC2.53%1,667,119$44.86MInstitution
Prosight Management LP2.35%1,550,000$41.71MInstitution
Ameriprise Financial Inc2.16%1,424,674$38.34MInstitution
Dme Capital Management LP0.73%482,746$12.99MInstitution
Segall Bryant Hamill LLC0.65%426,412$11.47MInstitution
Point72 Asset Management LP0.50%332,125$8.94MInstitution
Renaissance Technologies LLC0.48%315,400$8.49MInstitution

1 of 3

LKFT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LKFT47.44%0.00%
NBTX11.77%0.00%
DMRA77.24%22.76%Net SellingNet Selling
TSHA89.39%10.61%Net SellingNet Selling
SRPT76.79%23.21%Net Selling

Lakefront Biotherapeutics Nv Stock Ownership FAQ

Who owns Lakefront Biotherapeutics Nv?

Lakefront Biotherapeutics Nv (NASDAQ: LKFT) is owned by 47.44% institutional shareholders, 0.00% Lakefront Biotherapeutics Nv insiders, and 52.56% retail investors. Gilead Sciences Inc is the largest individual Lakefront Biotherapeutics Nv shareholder, owning 16.71M shares representing 25.35% of the company. Gilead Sciences Inc's Lakefront Biotherapeutics Nv shares are currently valued at $480.01M.

If you're new to stock investing, here's how to buy Lakefront Biotherapeutics Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.